What is the study about? HER2-RADiCAL is investigating whether some people with HER2 positive breast cancer can safely receive less treatment after surgery. HER2 is a protein which can cause cancer to ...
New research has found that a rare form of triple-negative breast cancer has a generally favourable long-term prognosis and may not require the same treatment approach as more common triple-negative ...
The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to ...
Researchers have taken an important step towards improving the diagnosis and management of prostate cancer by demonstrating that a quantitative imaging technique can accurately assess tumour ...
Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research ...
Research Data Manager: Integrative Cancer Epidemiology Email: [email protected] Location: Sutton Email: [email protected] Location: Sutton Home Research and discoveries Find a researcher ...
A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports. Almost half of the patients in the trial that could be evaluated saw their tumour shrink after ...
A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...
A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has ...
As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...
Up to two in five advanced prostate cancer patients could be treated with a combination of two targeted drugs, according to new research. Findings by a team of scientists at The Institute of Cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results